Drug company Mayne Pharma is pushing back against US-based Cosette Pharmaceutical's second attempt to terminate a proposed ...

Israel’s strike on Iran rattled markets and raised fears of oil disruption — another reminder that in today’s economy, ...

The Australian sharemarket closed lower as huge gains in the energy and utilities sectors - buoyed by advancing oil prices as ...

Vulcan Energy has secured approval and building permits for the 30 megawatt (MW) geothermal renewable energy plant and ...

A closely-watched US$22 billion ($33.7 billion) auction of 30-year US Treasury bonds drew solid demand, with investors ...

Chime Financial’s shares jumped as much as 66.4% in its trading debut after raising US$864 million ($1.32 billion) in an ...

Bell Potter has placed a 'sell' rating on Cettire after the luxury retail platform missed earnings estimates on Thursday, ...

Australian shares are set to open higher after all three US indices closed higher overnight, spurred by a 13% jump by ...

Former iflix CEO Mark Britt has emerged from stealth mode with tmrw, an AI-driven preventive health platform which has ...

The sale of 23andMe's genetic database to Regeneron shows gaps in Australia's cross-border data protection laws for sensitive ...

The government’s failure to act on AI is hurting productivity and living standards — Australia needs a clear, urgent strategy ...

The Los Angeles-based AI firm is in talks with Australian publishers after finalising deals with the men's publisher Man of ...